Marco Investment Management’s Elevance Health ELV Stock Holding History

Marco Investment Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,100	Closed	-$407K	–	182
2016 Q2	$407K	Hold	3,100	–	–	0.08%	143
2016 Q1	$431K	Hold	3,100	–	–	0.06%	142
2015 Q4	$432K	Hold	3,100	–	–	0.08%	142
2015 Q3	$434K	Hold	3,100	–	–	0.09%	136
2015 Q2	$509K	Hold	3,100	–	–	0.09%	133
2015 Q1	$479K	Hold	3,100	–	–	0.08%	131
2014 Q4	$388K	Hold	3,100	–	–	0.05%	151
2014 Q3	$371K	Hold	3,100	–	–	0.05%	151
2014 Q2	$334K	Hold	3,100	–	–	0.06%	148
2014 Q1	$309K	Hold	3,100	–	–	0.06%	149
2013 Q4	$286K	Hold	3,100	–	–	0.02%	150
2013 Q3	$259K	Buy	+3,100	New	+$266K	0.06%	149

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Marco Investment Management's ELV Position: Q3 2016 in Review

Marco Investment Management sold out of Elevance Health (ELV) in Q3 2016, closing a stake of 3,100 shares — an estimated $407K sold.

Marco Investment Management first reported a position in ELV in Q3 2013 and held it in 12 quarters. The position peaked at $509K in Q2 2015. 737 funds tracked by Wall St. Rank hold ELV as of Q3 2016.

Marco Investment Management reported no remaining Elevance Health position as of Q3 2016 after selling out during the quarter.
Marco Investment Management sold 3,100 Elevance Health shares in Q3 2016, an estimated $407K.
Marco Investment Management first reported a position in Elevance Health in Q3 2013 and held it in 12 quarters.
Marco Investment Management's Elevance Health position peaked at $509K in Q2 2015.
737 funds tracked by Wall St. Rank held Elevance Health as of Q3 2016.

Based on Marco Investment Management's 13F filing for Q3 2016, filed 15 Nov 2016.